Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-06-22
2000-09-05
Seaman, D. Margaret
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
514310, A61K 3147, C07D21722
Patent
active
061145300
ABSTRACT:
Disclosed are compounds that are highly selective partial agonists or antagonists at human CRF.sub.1 receptors that are useful in the diagnosis and treatment of treating stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety. The compounds have the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein Ar, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and W are various organic and inorganic substituents.
REFERENCES:
patent: 3274185 (1966-09-01), Sigal et al.
patent: 3753988 (1973-08-01), Rodway et al.
patent: 4956371 (1990-09-01), Shoupe
Sindler-Kulyk, M. et al., "Photocycloaddition Reactions of 3-Phenyl-1,2-benzisothiazole and Alkynes", Journal of Org. Chem., vol. 48 No. 8, 1983, pp. 1275-1281.
Holava, H. M. Jr. et al., "1-Substituted 4-Aryl- (or 4-Aralkyl-) phthalazines", New Compounds, vol. 12, 1969, pp. 555-556.
Yoon Taeyoung
Yuan Jun
Neurogen Corporation
Sarussi Steven J.
Seaman D. Margaret
LandOfFree
Isoquinolinamine and phthalazinamine derivatives: corticotropin- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinolinamine and phthalazinamine derivatives: corticotropin-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinolinamine and phthalazinamine derivatives: corticotropin- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2213513